https://www.taxtmi.com/caselaws?id=205886 Calcium Borogluconate Injection and Calcium Magnesium Borogluconate Injection were treated as eligible for exemption under Notifications No. 3/2001-CE, 6/2002-CE and 4/2006-CE on the basis that they fell within the category of intravenous fluid. The Tribunal followed its earlier decision in the assessee's own case, where the same product had already been granted the benefit of those notifications, and found no reason to depart from that view. The Revenue's challenge therefore failed, and the exemption position remained undisturbed. en-us Wed, 24 Aug 2011 00:00:00 +0530 Tue, 13 Sep 2011 17:27:00 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=205886 Calcium Borogluconate Injection and Calcium Magnesium Borogluconate Injection were treated as eligible for exemption under Notifications No. 3/2001-CE, 6/2002-CE and 4/2006-CE on the basis that they fell within the category of intravenous fluid. The Tribunal followed its earlier decision in the assessee's own case, where the same product had already been granted the benefit of those notifications, and found no reason to depart from that view. The Revenue's challenge therefore failed, and the exemption position remained undisturbed. Case-Laws Central Excise Wed, 24 Aug 2011 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=205886